Peer Review, UGC Care
LIGAND BASED DRUG DESIGN STRATEGY FOR THE MODELING OF PHENYLALKYLAMINES AS A PSYCHOTOMIMETIC AGENT
View PDF

Keywords

Ligand based drug design,Phenylalkylamines, QSAR, Psychotomimetic agents.

How to Cite

Thakur, A. ., Thakur, M. ., & Gade, J. V. . (2015). LIGAND BASED DRUG DESIGN STRATEGY FOR THE MODELING OF PHENYLALKYLAMINES AS A PSYCHOTOMIMETIC AGENT. International Journal of Research and Development in Pharmacy & Life Sciences, 4(6), 1838-1845. Retrieved from https://ijrdpl.com/index.php/ijrdpl/article/view/426

Abstract

Quantitative Structure Activity Relationship (QSAR) studies of 49 Phenyl alkyl amines derivatives have been performed using various structural descriptors, volumetric parameters and hydrophobic properties of the compounds. These derivatives are used as psychotomimetic agent. In present work, QSAR were determined by using multiple linear regression method (MLR). Five molecular descriptors accounting for the substitution at 2nd and 5th position, hydrophobicity, Surface area, branching and molar refractivity of the compounds were selected by stepwise regression method to built QSAR models. The study was further narrowed down by using modeling parameter on the selected set of compounds; results illustrate the importance of dipole moment and total energy on the psychotomimetic activity of the compounds.

View PDF

References

Glennon R.A, (1999), Pharmacol. Biochem. Behav. 64, 251

Taurian O. E,Contreras R. H, (2000), J. Mol. Struct. (Theochem) 504, 119

Nieforth K. A, (1971),J. Pharm. Sci. 60, 655

Synder S. H, Merril C. R, (1965), Natl. Acad. Sci. U.S.A. 54, 258

MracecM, Mracec M, Kurunczi L., Nussar T., Simon Z., Naray-Szabo G., (1996), J. Mol. Str. (Theochem) 367, 139.

Thakur M., Thakur A., Khadikar P. V., (2004), Bioorg. Med. Chem. 12, 825

Altun A., Golcuk K., Kumru M., Jalbout A. F., (2003), Bioorg. Med. Chem. 11,3861

Braun, U.,Braun, G., Jacob, P., III;Nichols, D. E.; Shulgin,

A.T. In QSAR Research Monograph;Branett, G., Trsic, M., Rillette, R., Eds.;NIDA: Rockville, 1978;Vol. 22, p 27.

Hopman, G.,Macina, O. T.( 1985) J. Theor. Biol. 113, 637.

Clare, B. W. (1990), Med. Chem., 33, 687.

Nichols, D. E.,Oberlendor, R.,McKenna, D. J(1991). Biochemistry and Physiology of Substance Abuse;Watson, R. R., Ed.;RC: Boca Raton, Boston, Vol. III, p 5.

Glennon, R. A.,Dukat, M. (1991)Pharmacol. Biochem. Bolav. 40, 1009.

Glennon, R. A.,Raghupati, R., Bartyzel, P.,Titler, M., Leonhadt, S. J.(1992) Med. Chem. 35, 734.

Westakaemper, R. B.;Glennon, R. A.(1993), Med. Chem. Res.3, 317.

Ruffolo, R. R.(1993) Drug Design Discov. 9, 351.

Tarciso, V.,Meroni, R.,Dagani, R.,Baldi, G.,Paghi, M., Bevilaquen, M.,Norriato, G. J. (1985) Pharm. Pharmacol., 37, 593.

Srlurojer, T.,Hodsiek, M.,Hadzi, D.,Lukovits, I.(1984), QSAR Pharmacol. Chem. Bio. 3, 51.

Wiener, H. J.(1947), Am.Chem. Soc. 69, 17.

Balaban, A. T.(1982) Chem. Phys. Lett., 89, 399.

Khadikar, P. V.,Deshpande, N. N.,Kali, P. A.,Dohirnin, A.,Gutman, I.,Donewfor, G. J.(1995) Chem. Inf. Compt. Sci., 35, 547.

Shultz, H. P. (1989),J. Chem. Inf. Comp Sci., 29, 227.

Kier, L.B.; Hall, L.H. (1997), J. Chem. Inf. Comp. Sci., 37, 548.

Randic, M. (1975),J. Am.Chem. Soc., 97, 6609.

Croux C, Joossens K (2005). J Multivar Anal 96:348.

Devillers J (1996) Academic Press, London

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Copyright (c) 2020 Array

Downloads

Download data is not yet available.